STOUGHTON, Mass. (AP) — STOUGHTON, Mass. (AP) — Collegium Pharmaceutical Inc. (COLL) on Tuesday reported third-quarter net income of $20.6 million.
The Stoughton, Massachusetts-based company said it had profit of 53 cents per share. Earnings, adjusted for one-time gains and costs, were $1.34 per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.24 per share.
The specialty pharmaceutical company posted revenue of $136.7 million in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $139.5 million.
Collegium Pharmaceutical expects full-year revenue in the range of $565 million to $570 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on COLL at https://www.zacks.com/ap/COLL